View Filing Data

Leases (Amounts Reported in Unaudited and Audited Condensed Consolidated Balance Sheets for Operating Leases) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease assets, net	$ 20,703	$ 21,111
Short-term operating lease liabilities (in accrued expenses)	$ 7,425	$ 7,234
Operating lease, liability, current, statement of financial position [Extensible List]	us-gaap:AccruedLiabilitiesCurrent	us-gaap:AccruedLiabilitiesCurrent
Long-term operating lease liabilities	$ 13,638	$ 14,301
Total operating lease liabilities	$ 21,063	$ 21,535

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash	$ 130,463	$ 111,714
Accounts receivable, net	141,083	149,680
Prepaid expenses and other current assets	6,505	7,993
Total current assets	278,051	269,387
Property and equipment, net of accumulated depreciation and amortization	13,791	12,156
Other assets
Goodwill	275,364	275,368
Intangibles, net of accumulated amortization	55,304	57,079
Deferred tax assets, net	1,606	1,647
Operating lease assets, net	20,703	21,111
Total other assets	352,977	355,205
Total assets	644,819	636,748
Current liabilities
Accounts payable	17,561	19,641
Accrued payroll	29,476	30,587
Accrued expenses	22,116	22,429
Accrued workers’ compensation insurance	14,497	14,143
Current portion of long-term debt	956	728
Total current liabilities	84,606	87,528
Long-term liabilities
Long-term debt, less current portion, net of debt issuance costs	59,112	59,164
Long-term operating lease liabilities	13,638	14,301
Other long-term liabilities	655	163
Total long-term liabilities	73,405	73,628
Total liabilities	158,011	161,156
Stockholders’ equity
Common stock—$.001 par value; 40,000 authorized and 15,660 and 15,617 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	16	15
Additional paid-in capital	362,102	359,545
Retained earnings	124,690	116,032
Total stockholders’ equity	486,808	475,592
Total liabilities and stockholders’ equity	$ 644,819	$ 636,748

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2018	$ 268,491	$ 13	$ 177,683	$ 90,795
Balance, shares at Dec. 31, 2018		13,126
Issuance of shares of common stock under restricted stock award agreements		52
Stock-based compensation	1,233		1,233
Net income	4,296			4,296
Balance at Mar. 31, 2019	274,020	$ 13	178,916	95,091
Balance, shares at Mar. 31, 2019		13,178
Balance at Dec. 31, 2019	475,592	$ 15	359,545	116,032
Balance, shares at Dec. 31, 2019		15,617
Forfeiture of shares of common stock under restricted stock award agreements, shares		(5)
Stock-based compensation	1,407		1,407
Shares issued for exercise of stock options	1,151	$ 1	1,150
Shares issued for exercise of stock options, shares		48
Net income	8,658			8,658
Balance at Mar. 31, 2020	$ 486,808	$ 16	$ 362,102	$ 124,690
Balance, shares at Mar. 31, 2020		15,660

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Commitments and Contingencies (Narrative) (Details) $ in Billions	Apr. 24, 2020 USD ($)
CARES Act and PPPHCE Act [Member] \| Subsequent Event [Member]
Commitments And Contingencies [Line Items]
Authorized fund to be distributed to health care providers	$ 175

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include revenue recognition, accounts receivable and allowances and goodwill and intangible assets. Actual results could differ from those estimates.

Diluted Net Income Per Common Share

Diluted net income per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company’s outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards.

As of March 31, 2020 and 2019, dilutive stock options outstanding were approximately 585,000 and 685,000, respectively, and dilutive restricted stock awards outstanding were approximately 77,000 and 83,000, respectively

Included in the Company’s calculation of diluted earnings per share for the three months ended March 31, 2020, dilutive stock options outstanding were approximately 311,000. In addition, dilutive restricted stock awards outstanding were 84,000 for the three months ended March 31, 2020.

Included in the Company’s calculation of diluted earnings per share for the three months ended March 31, 2019, dilutive stock options outstanding were approximately 303,000. In addition, dilutive restricted stock awards outstanding were 153,000 for the three months ended March 31, 2019.

Recently Adopted Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. We have reviewed our provision for doubtful accounts process as required by ASU 2016-13. Management estimates allowances on accounts receivable based upon historical experience and other factors, including an aging of accounts receivable, evaluation of expected adjustments, past adjustments and collection experience in relation to amounts billed, current contract and reimbursement terms, shifts in payors and other current relevant information. The Company recorded $0.2 million of provision for doubtful accounts for three months ended March 31, 2020. Allowance for doubtful accounts was $0.8 million and $1.0 million as of March 31, 2020 and December 31, 2019, respectively. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The new guidance eliminates the requirement to calculate the implied fair value of goodwill (i.e., Step 2 of the current goodwill impairment test) to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value (i.e., measure the charge based on the current Step 1). Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. ASU 2018-15 requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in Accounting Standards Codification (“ASC”) 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

Recently Issued Accounting Pronouncements

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 intends to simplify various aspects related to accounting for income taxes and removes certain exceptions to the general guidance in ASC 740. In addition, the ASU clarifies and amends existing guidance to improve consistent application of its requirements. The ASU is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. Adoption of the new standard is not expected to have an impact on our results of operations or liquidity.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, and other transactions subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. Therefore, it will be in effect for a limited time through December 31, 2022. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is evaluating the effect of adopting this new accounting guidance.

Long-Term Debt (Schedule of Long-Term Debt) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Financing leases	$ 12	$ 21
Less unamortized issuance costs	(2,267)	(2,452)
Total	60,068	59,892
Less current maturities	(956)	(728)
Long-term debt	59,112	59,164
Revolving Credit Loan [Member] \| Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt gross	43,458	43,458
Term Loan [Member] \| Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt gross	$ 18,865	$ 18,865

Income Taxes

3 Months Ended

Mar. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes

9. Income Taxes

The effective income tax rate was 14.2% and 15.6% for the three months ended March 31, 2020 and 2019, respectively. The difference between our federal statutory and effective income tax rates was principally due to the inclusion of excess tax benefit and the use of federal employment tax credits, partially offset by state taxes.

The effective tax rates are lower than the federal statutory rate primarily due to the inclusion of a 12.2% and 8.7% excess tax benefit for the three months ended March 31, 2020 and 2019, respectively. The excess tax benefit is a discrete item which requires the Company to recognize the benefit fully in the quarter.

Segment Information (Narrative) (Details)	3 Months Ended
Segment Information (Narrative) (Details)	Mar. 31, 2020 segment
Segment Reporting [Abstract]
Number of business segments	3

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2020

Goodwill And Intangible Assets Disclosure [Abstract]

Summary of Goodwill and Related Adjustments

A summary of the goodwill activity for the three months ended March 31, 2020 is provided below:

	Goodwill
	Personal Care			Hospice		Home Health		Total
	(Amounts in Thousands)
Goodwill as of December 31, 2019	$	126,577		$	146,983	$	1,808	$	275,368
Adjustments to previously recorded goodwill		(71	)		31		36		(4	)
Goodwill as of March 31, 2020	$	126,506		$	147,014	$	1,844	$	275,364

Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following as of March 31, 2020:

	Customer and referral relationships			Trade names and trademarks			Non- competition agreements			State Licenses			Total
	(Amounts in Thousands)
Intangible assets with indefinite lives		—			—			—			13,306			13,306
Intangible assets subject to amortization:
Gross carrying amount		48,028			31,036			4,655			12,020			95,739
Accumulated amortization		(36,197	)		(13,537	)		(2,402	)		(1,605	)		(53,741	)
Intangible assets subject to amortization, net		11,831			17,499			2,253			10,415			41,998
Total intangible assets at March 31, 2020	$	11,831		$	17,499		$	2,253		$	23,721		$	55,304

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Goodwill [Line Items]
Amortization expense	$ 1.8	$ 1.3
Weighted average remaining lives of identifiable intangible assets	8 years 9 months 18 days
Minimum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives	3 years
Minimum [Member] \| Customer and Referral Relationships [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives	5 years
Maximum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives	25 years
Maximum [Member] \| Customer and Referral Relationships [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives	10 years

Acquisitions (Tables)

3 Months Ended

Mar. 31, 2020

Hospice Partners [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	112,283
Identifiable intangible assets		18,090
Cash		5,705
Property and equipment		164
Accounts receivable		6,788
Operating lease assets, net		2,425
Other assets		632
Accounts payable		(1,631	)
Accrued expenses		(4,625	)
Accrued payroll		(1,108	)
Deferred tax liability		(1,540	)
Long-term operating lease liabilities		(1,615	)
Total purchase price	$	135,568

Alliance Home Health Care [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s final valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	16,859
Identifiable intangible assets		5,422
Cash		173
Accounts receivable		1,796
Accounts payable		(302	)
Other liabilities		(490	)
Total purchase price	$	23,458

VIP Health Care Services [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	10,544
Identifiable intangible assets		15,370
Cash		110
Accounts receivable		6,064
Operating lease assets, net		2,278
Other assets		30
Property and equipment		27
Accounts payable		(462	)
Accrued expenses		(770	)
Accrued payroll		(1,742	)
Long-term operating lease liabilities		(1,531	)
Total purchase price	$	29,918

Hospic Partners, Alliance and VIP [Member]

Business Acquisition [Line Items]

Unaudited Pro Forma Condensed Consolidated Income Statement Information

The following table contains unaudited pro forma condensed consolidated income statement information of the Company for the three months ended March 31, 2019 as if each of the acquisitions of Hospice Partners, Alliance and VIP closed on January 1, 2019.

	For the Three Months Ended March 31, 2019 (Amounts in Thousands)
Net service revenues	$	171,487
Operating income		10,042
Net income		8,113
Net income per common share
Basic income per share	$	0.62

Long-Term Debt (Narrative) (Details) - USD ($)		1 Months Ended		3 Months Ended
Long-Term Debt (Narrative) (Details) - USD ($)	Sep. 12, 2019	Oct. 31, 2018	Oct. 30, 2018	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt issuance costs				$ 2,267,000	$ 2,452,000
Credit Agreement [Member] \| Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		$ 269,600,000		$ 218,500,000	191,400,000
Debt instrument, maturity date				May 08, 2023
Debt instrument total net leverage ratio			4.25%
Debt issuance costs		900,000
Line of credit outstanding amount				$ 9,600,000	10,000,000.0
Credit Agreement [Member] \| Capital One, National Association [Member] \| Delayed Draw Term Loan [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		$ 19,600,000
Credit Agreement [Member] \| Capital One, National Association [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Line of credit outstanding amount				$ 18,900,000	$ 18,900,000
Debt instrument stated interest rate				2.74%	3.45%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument total net leverage ratio		3.75%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		0.50%
Credit Agreement [Member] \| Capital One, National Association [Member] \| London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		1.00%
Credit Agreement [Member] \| Capital One, National Association [Member] \| London Interbank Offered Rate (LIBOR) \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		0.00%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Senior Leverage Ratio \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		0.75%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Senior Leverage Ratio \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		1.50%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Leverage Ratio [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		1.75%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Leverage Ratio [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin		2.50%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Restriction on Dividends [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Aggregate amount of dividends and distributions				$ 7,500,000
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available	$ 300,000,000.0	$ 250,000,000.0
Increase in credit facility	50,000,000.0
Debt issuance costs	$ 400,000
Proceeds from line of credit				0
Line of credit outstanding amount				$ 43,400,000	$ 43,400,000
Debt instrument stated interest rate				3.33%	3.44%
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility				0.20%
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility				0.35%

Segment Information (Segment Reconciliation to Totals reported in the accompanying Consolidated Financial Statements) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Operating income	$ 10,661	$ 5,496
Other general and administrative expenses	19,205	14,442
Depreciation and amortization	2,887	2,074
Interest income	(334)	(215)
Interest expense	908	618
Income before income taxes	10,087	5,093
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating income	$ 32,753	$ 22,012

Significant Payors (Revenue by Payor Type) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net service revenues	$ 190,216	$ 138,507
Personal Care [Member]
Net service revenues	160,665	127,894
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues	$ 160,665	$ 127,894
Concentration risk, percentage	100.00%	100.00%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| State, Local And Other Governmental Programs [Member]
Net service revenues	$ 79,346	$ 71,642
Concentration risk, percentage	49.40%	56.00%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues	$ 72,110	$ 47,726
Concentration risk, percentage	44.90%	37.30%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Private Pay [Member]
Net service revenues	$ 5,270	$ 4,990
Concentration risk, percentage	3.30%	3.90%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Commercial Insurance [Member]
Net service revenues	$ 2,576	$ 1,856
Concentration risk, percentage	1.60%	1.50%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues	$ 1,363	$ 1,680
Concentration risk, percentage	0.80%	1.30%
Hospice [Member]
Net service revenues	$ 25,212	$ 7,917
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues	$ 25,212	$ 7,917
Concentration risk, percentage	100.00%	100.00%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Medicare [Member]
Net service revenues	$ 23,219	$ 7,390
Concentration risk, percentage	92.10%	93.30%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues	$ 1,385	$ 361
Concentration risk, percentage	5.50%	4.60%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues	$ 608	$ 166
Concentration risk, percentage	2.40%	2.10%
Home Health [Member]
Net service revenues	$ 4,339	$ 2,696
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues	$ 4,339	$ 2,696
Concentration risk, percentage	100.00%	100.00%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Medicare [Member]
Net service revenues	$ 3,470	$ 2,199
Concentration risk, percentage	80.00%	81.60%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues	$ 807	$ 414
Concentration risk, percentage	18.60%	15.40%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues	$ 62	$ 83
Concentration risk, percentage	1.40%	3.00%

Details of Certain Balance Sheet Accounts (Schedule of Prepaid Expenses and Other Current Assets) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Details Of Certain Balance Sheet Accounts [Abstract]
Workers’ compensation insurance receivable	$ 2,140	$ 1,989
Prepaid workers’ compensation and liability insurance	1,324	2,040
Health insurance receivable	126	1,567
Other	2,915	2,397
Total prepaid expenses and other current assets	$ 6,505	$ 7,993

Significant Payors

3 Months Ended

Mar. 31, 2020

Significant Payors [Abstract]

Significant Payors

12. Significant Payors

For the three months ended March 31, 2020 and 2019 the Company’s revenue by payor type was as follows:

	Personal Care
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
State, local and other governmental programs	$	79,346		49.4	%	$	71,642		56.0	%
Managed care organizations		72,110		44.9			47,726		37.3
Private pay		5,270		3.3			4,990		3.9
Commercial insurance		2,576		1.6			1,856		1.5
Other		1,363		0.8			1,680		1.3
Total personal care segment net service revenues	$	160,665		100.0	%	$	127,894		100.0	%

	Hospice
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	23,219		92.1	%	$	7,390		93.3	%
Managed care organizations		1,385		5.5			361		4.6
Other		608		2.4			166		2.1
Total hospice segment net service revenues	$	25,212		100.0	%	$	7,917		100.0	%

	Home Health
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	3,470		80.0	%	$	2,199		81.6	%
Managed care organizations		807		18.6			414		15.4
Other		62		1.4			83		3.0
Total home health segment net service revenues	$	4,339		100.0	%	$	2,696		100.0	%

The Company derives a significant amount of its revenue from its operations in Illinois, New York and New Mexico. The percentages of segment revenue for each of these significant states for the three months ended March 31, 2020 and 2019 were as follows:

	Personal Care
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Illinois	$	71,545		44.5	%	$	56,849		44.4	%
New York		31,838		19.8			17,813		13.9
New Mexico		20,694		12.9			17,208		13.5
All other states		36,588		22.8			36,024		28.2
Total personal care segment net service revenues	$	160,665		100.0	%	$	127,894		100.0	%

	Hospice
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	11,009		43.7	%	$	7,917		100.0	%
All other states		14,203		56.3			—		—
Total hospice segment net service revenues	$	25,212		100.0	%	$	7,917		100.0	%

	Home Health
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	4,339		100.0	%	$	2,696		100.0	%
Total home health segment net service revenues	$	4,339		100.0	%	$	2,696		100.0	%

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state and local governmental agencies. We derive a significant amount of our net service revenues in Illinois, which represented 37.7%, and 41.0% of our net service revenues for the three months ended March 31, 2020, and 2019, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 23.2% and 29.1% of the Company’s net service revenues for the three months ended March 31, 2020 and 2019, respectively.

The related receivables due from the Illinois Department on Aging represented 18.7% and 25.1% of the Company’s net accounts receivable at March 31, 2020 and December 31, 2019, respectively.

Details of Certain Balance Sheet Accounts (Schedule of Accrued Expenses) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Details Of Certain Balance Sheet Accounts [Abstract]
Current portion of operating lease liabilities	$ 7,425	$ 7,234
Accrued professional fees	3,806	2,517
Accrued health insurance	3,519	4,140
Other	7,366	8,538
Total accrued expenses	$ 22,116	$ 22,429

Details of Certain Balance Sheet Accounts

3 Months Ended

Mar. 31, 2020

Details Of Certain Balance Sheet Accounts [Abstract]

Details of Certain Balance Sheet Accounts

7. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:

	March 31, 2020		December 31, 2019
	(Amounts in Thousands)
Workers’ compensation insurance receivable	$	2,140	$	1,989
Prepaid workers’ compensation and liability insurance		1,324		2,040
Health insurance receivable		126		1,567
Other		2,915		2,397
Total prepaid expenses and other current assets	$	6,505	$	7,993

Accrued expenses consisted of the following:

	March 31, 2020		December 31, 2019
	(Amounts in Thousands)
Current portion of operating lease liabilities	$	7,425	$	7,234
Accrued professional fees		3,806		2,517
Accrued health insurance		3,519		4,140
Other		7,366		8,538
Total accrued expenses	$	22,116	$	22,429

Revision of Previously Issued Financial Statements (Tables)

3 Months Ended

Mar. 31, 2020

Accounting Changes And Error Corrections [Abstract]

Schedule of Error Corrections and Prior Period Adjustments

The Consolidated Statements of Income has been revised to reflect the correction for the three months ended March 31, 2019 as follows (amounts in thousands, except per share data):

	For the Three Months Ended March 31, 2019
	As
	Previously					As
	Reported		Revision			Revised
Net service revenues	$	139,254	$	(747	)	$	138,507
Gross profit		37,574		(747	)		36,827
Operating income		6,243		(747	)		5,496
Income before income taxes		5,840		(747	)		5,093
Income tax expense		978		(181	)		797
Net income	$	4,862	$	(566	)	$	4,296
Basic income per share	$	0.37	$	(0.04	)	$	0.33
Diluted income per share	$	0.36	$	(0.04	)	$	0.32

The cumulative effect of the adjustments on all prior periods decreased retained earnings as of January 1, 2019 and March 31, 2019 as reflected below (amounts in thousands):

	Common Stock				Additional Paid in Capital		Retained Earnings			Total Stockholders' Equity
	Shares		Amount
Balance at January 1, 2019		13,126	$	13	$	177,683	$	97,837		$	275,533
Revision		—		—		—		(7,042	)		(7,042	)
Balance at January 1, 2019, as revised		13,126	$	13	$	177,683	$	90,795		$	268,491

Balance at March 31, 2019		13,178	$	13	$	178,916	$	102,699		$	281,628
Revision		—		—		—		(7,608	)		(7,608	)
Balance at March 31, 2019, as revised		13,178	$	13	$	178,916	$	95,091		$	274,020

Additionally, the Consolidated Statement of Cash Flows has been revised to reflect the correction for the three months ended March 31, 2019 as follows (amounts in thousands):

	For the Three Months Ended March 31, 2019
	As
	Previously						As
	Reported			Revision			Revised
Net income	$	4,862		$	(566	)	$	4,296
Deferred income taxes		121			(181	)		(60	)
Accounts receivable		(12,989	)		747			(12,242	)
Net cash provided by operating activities	$	(3,197	)	$	—		$	(3,197	)

Long-Term Debt

3 Months Ended

Mar. 31, 2020

Long Term Debt [Abstract]

Long-Term Debt

8. Long-Term Debt

Long-term debt consisted of the following:

	March 31, 2020			December 31, 2019
	(Amounts in Thousands)
Revolving loan under the credit facility	$	43,458		$	43,458
Term loan under the credit facility		18,865			18,865
Financing leases		12			21
Less unamortized issuance costs		(2,267	)		(2,452	)
Total	$	60,068		$	59,892
Less current maturities		(956	)		(728	)
Long-term debt	$	59,112		$	59,164

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, dated as of October 31, 2018, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders (as amended by the Amendment (as hereinafter defined), the “Credit Agreement”), which amended and restated the Company’s existing credit agreement. This credit facility totaled $269.6 million, inclusive of a $250.0 million revolving loan and a $19.6 million delayed draw term loan, and is evidenced by the Credit Agreement. This credit facility amended and restated the Company’s existing senior secured credit facility totaling $250.0 million. As used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement. The maturity of this credit facility is May 8, 2023. Interest on the Company’s credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50% and (c) the sum of the adjusted LIBOR that would be applicable to a loan with an interest period of one month advanced on the applicable day (not to be less than 0.00%) plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the offered rate per annum for similar dollar deposits for the applicable interest period that appears on Reuters Screen LIBOR01 Page (not to be less than zero). Swing loans may not be LIBOR loans. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters. In connection with this amended and restated credit facility, the Company incurred approximately $0.9 million of debt issuance costs.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this amended and restated credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions and dispositions of assets.

On September 12, 2019, the Company entered into a First Amendment (the “Amendment”) to its Credit Agreement. The Amendment increased the Company’s credit facility by $50.0 million in incremental revolving loans, for an aggregate $300.0 million in revolving loans. The Amendment provides that future incremental loans may be for term loans or an increase to the revolving loan commitments. The Amendment further provides that the proceeds of the incremental revolving loan commitments may be used for, among other things, general corporate purposes. In connection with the modification of this Amendment, the Company incurred approximately $0.4 million of debt issuance costs.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the amended and restated credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement), a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum permitted amount of capital expenditures, as well as restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $7.5 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement thresholds), restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business. As of March 31, 2020, the Company was in compliance with all financial covenants under the Credit Agreement. However, the Company was unable to timely file its Annual Report on Form 10-K, which would have included its audited financial statements for the year ended December 31, 2019. The Company is required to deliver annual audited financial statements under the affirmative covenants of its Credit Agreement. The Company obtained consent from the Required Lenders (as defined in the Credit Agreement) to extend the timeline of the audited financials for the year ended December 31, 2019 to not later than October 31, 2020.

During the three months ended March 31, 2020, the Company had no draws under its credit facility.

As of March 31, 2020, the Company had a total of $43.4 million of revolving loans, with an interest rate of 3.33% and $18.9 million of term loans, with an interest rate of 2.74%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $9.6 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $218.5 million available for borrowing under its credit facility.

As of December 31, 2019, the Company had a total of $43.4 million of revolving loans, with an interest rate of 3.44%, and $18.9 million of term loans, with an interest rate of 3.45%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $10.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $191.4 million available for borrowing under its credit facility.

Segment Information (Summary Of Segment Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Net service revenues	$ 190,216	$ 138,507
Cost of services revenues	134,381	101,680
Gross profit	55,835	36,827
General and administrative expenses	42,287	29,257
Operating income	10,661	5,496
Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	23,082	14,815
Operating income	32,753	22,012
Personal Care [Member]
Segment Reporting Information [Line Items]
Net service revenues	160,665	127,894
Cost of services revenues	119,027	95,995
Gross profit	41,638	31,899
Personal Care [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	15,603	12,539
Operating income	26,035	19,360
Hospice [Member]
Segment Reporting Information [Line Items]
Net service revenues	25,212	7,917
Cost of services revenues	12,318	3,770
Gross profit	12,894	4,147
Hospice [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	6,457	1,590
Operating income	6,437	2,557
Home Health [Member]
Segment Reporting Information [Line Items]
Net service revenues	4,339	2,696
Cost of services revenues	3,036	1,915
Gross profit	1,303	781
Home Health [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	1,022	686
Operating income	$ 281	$ 95

Leases (Supplemental Cash Flows Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 2,171	$ 1,639
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 1,439	$ 801

Leases (Narrative) (Details)	3 Months Ended
Leases (Narrative) (Details)	Mar. 31, 2020
Lessee Lease [Line Items]
Operating lease expiration dates	expiration dates through 2026
Minimum [Member]
Lessee Lease [Line Items]
Leases termination and renewal option	1 year
Maximum [Member]
Lessee Lease [Line Items]
Leases termination and renewal option	5 years

Acquisitions (Schedule of Fair Values of Assets and Liabilities) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Oct. 01, 2019	Aug. 01, 2019	Jun. 01, 2019
Business Acquisition [Line Items]
Goodwill	$ 275,364	$ 275,368
Hospice Partners [Member]
Business Acquisition [Line Items]
Goodwill			$ 112,283
Identifiable intangible assets			18,090
Cash			5,705
Property and equipment			164
Accounts receivable			6,788
Operating lease assets, net			2,425
Other assets			632
Accounts payable			(1,631)
Accrued expenses			(4,625)
Accrued payroll			(1,108)
Deferred tax liability			(1,540)
Long-term operating lease liabilities			(1,615)
Total purchase price			$ 135,568
Alliance Home Health Care [Member]
Business Acquisition [Line Items]
Goodwill				$ 16,859
Identifiable intangible assets				5,422
Cash				173
Accounts receivable				1,796
Accounts payable				(302)
Other liabilities				(490)
Total purchase price				$ 23,458
VIP Health Care Services [Member]
Business Acquisition [Line Items]
Goodwill					$ 10,544
Identifiable intangible assets					15,370
Cash					110
Property and equipment					27
Accounts receivable					6,064
Operating lease assets, net					2,278
Other assets					30
Accounts payable					(462)
Accrued expenses					(770)
Accrued payroll					(1,742)
Long-term operating lease liabilities					(1,531)
Total purchase price					$ 29,918

Document And Entity Information - shares shares in Thousands	3 Months Ended
	Mar. 31, 2020	Jul. 31, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020
Entity Registrant Name	ADDUS HOMECARE CORPORATION
Entity Central Index Key	0001468328
Trading Symbol	ADUS
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Current Reporting Status	No
Entity Address, State or Province	TX
Entity File Number	001-34504
Entity Tax Identification Number	20-5340172
Entity Address, Address Line One	6303 Cowboys Way
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Frisco
Entity Address, Postal Zip Code	75034
City Area Code	(469)
Local Phone Number	535-8200
Entity Common Stock, Shares Outstanding		15,664,952
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	No
Entity Incorporation, State or Country Code	DE
Title of 12(b) Security	Common Stock, $0.001 par value
Security Exchange Name	NASDAQ

Revision of Previously Issued Financial Statements (Consolidated Statements of Income) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net service revenues	$ 190,216	$ 138,507
Gross profit	55,835	36,827
Operating income	10,661	5,496
Income before income taxes	10,087	5,093
Income tax expense	1,429	797
Net income	$ 8,658	$ 4,296
Basic income per share	$ 0.56	$ 0.33
Diluted income per share	$ 0.54	$ 0.32
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net service revenues		$ 139,254
Gross profit		37,574
Operating income		6,243
Income before income taxes		5,840
Income tax expense		978
Net income		$ 4,862
Basic income per share		$ 0.37
Diluted income per share		$ 0.36
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net service revenues		$ (747)
Gross profit		(747)
Operating income		(747)
Income before income taxes		(747)
Income tax expense		(181)
Net income		$ (566)
Basic income per share		$ (0.04)
Diluted income per share		$ (0.04)

Summary of Significant Accounting Policies (Policies)	3 Months Ended
Summary of Significant Accounting Policies (Policies)	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2019 has been derived from the Company’s audited financial statements for the year ended December 31, 2019 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2019 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.
Principles of Consolidation	Principles of Consolidation These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Estimates	Estimates The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include revenue recognition, accounts receivable and allowances and goodwill and intangible assets. Actual results could differ from those estimates.
Diluted Net Income Per Common Share	Diluted Net Income Per Common Share Diluted net income per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company’s outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards. As of March 31, 2020 and 2019, dilutive stock options outstanding were approximately 585,000 and 685,000, respectively, and dilutive restricted stock awards outstanding were approximately 77,000 and 83,000, respectively Included in the Company’s calculation of diluted earnings per share for the three months ended March 31, 2020, dilutive stock options outstanding were approximately 311,000. In addition, dilutive restricted stock awards outstanding were 84,000 for the three months ended March 31, 2020. Included in the Company’s calculation of diluted earnings per share for the three months ended March 31, 2019, dilutive stock options outstanding were approximately 303,000. In addition, dilutive restricted stock awards outstanding were 153,000 for the three months ended March 31, 2019.
Recently Issued and Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. We have reviewed our provision for doubtful accounts process as required by ASU 2016-13. Management estimates allowances on accounts receivable based upon historical experience and other factors, including an aging of accounts receivable, evaluation of expected adjustments, past adjustments and collection experience in relation to amounts billed, current contract and reimbursement terms, shifts in payors and other current relevant information. The Company recorded $0.2 million of provision for doubtful accounts for three months ended March 31, 2020. Allowance for doubtful accounts was $0.8 million and $1.0 million as of March 31, 2020 and December 31, 2019, respectively. Adoption of the new standard did not have a significant impact on our results of operations or liquidity. In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The new guidance eliminates the requirement to calculate the implied fair value of goodwill (i.e., Step 2 of the current goodwill impairment test) to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value (i.e., measure the charge based on the current Step 1). Adoption of the new standard did not have a significant impact on our results of operations or liquidity. In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. ASU 2018-15 requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in Accounting Standards Codification (“ASC”) 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. Adoption of the new standard did not have a significant impact on our results of operations or liquidity. Recently Issued Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 intends to simplify various aspects related to accounting for income taxes and removes certain exceptions to the general guidance in ASC 740. In addition, the ASU clarifies and amends existing guidance to improve consistent application of its requirements. The ASU is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. Adoption of the new standard is not expected to have an impact on our results of operations or liquidity. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, and other transactions subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. Therefore, it will be in effect for a limited time through December 31, 2022. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is evaluating the effect of adopting this new accounting guidance.

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	15,660,000	15,617,000
Common stock, shares outstanding	15,660,000	15,617,000

Nature of Operations, Consolidation, and Presentation of Financial Statements

3 Months Ended

Mar. 31, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Nature of Operations, Consolidation, and Presentation of Financial Statements

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us” or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care services segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy. The Company’s payors include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2019 has been derived from the Company’s audited financial statements for the year ended December 31, 2019 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2019 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Leases (Summary of Remaining Operating Lease Payments) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Leases [Abstract]
2021	$ 8,117
2022	6,818
2023	4,160
2024	2,323
2025	1,382
Thereafter	158
Total future minimum rental commitments	22,958
Less: Imputed interest	(1,895)
Total lease liabilities	$ 21,063	$ 21,535

Details of Certain Balance Sheet Accounts (Tables)

3 Months Ended

Mar. 31, 2020

Details Of Certain Balance Sheet Accounts [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:

	March 31, 2020		December 31, 2019
	(Amounts in Thousands)
Workers’ compensation insurance receivable	$	2,140	$	1,989
Prepaid workers’ compensation and liability insurance		1,324		2,040
Health insurance receivable		126		1,567
Other		2,915		2,397
Total prepaid expenses and other current assets	$	6,505	$	7,993

Schedule of Accrued Expenses

Accrued expenses consisted of the following:

	March 31, 2020		December 31, 2019
	(Amounts in Thousands)
Current portion of operating lease liabilities	$	7,425	$	7,234
Accrued professional fees		3,806		2,517
Accrued health insurance		3,519		4,140
Other		7,366		8,538
Total accrued expenses	$	22,116	$	22,429

Revision of Previously Issued Financial Statements (Consolidated Statement of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income	$ 8,658	$ 4,296
Deferred income taxes	42	(60)
Accounts receivable	8,777	(12,242)
Net cash provided by operating activities	$ 20,442	(3,197)
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income		4,862
Deferred income taxes		121
Accounts receivable		(12,989)
Net cash provided by operating activities		(3,197)
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income		(566)
Deferred income taxes		(181)
Accounts receivable		$ 747

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686

+ Details

Segment Information

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Segment Information

11. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s chief operating decision makers, to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three distinct but related business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy.

The tables below set forth information about the Company’s reportable segments for the three months ended March 31, 2020 and 2019 along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements. Segment assets are not reviewed by the Company’s chief operating decision maker function and therefore are not disclosed below.

Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

	For the Three Months Ended March 31, 2020
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	160,665	$	25,212	$	4,339	$	190,216
Cost of services revenues		119,027		12,318		3,036		134,381
Gross profit		41,638		12,894		1,303		55,835
General and administrative expenses		15,603		6,457		1,022		23,082
Segment operating income	$	26,035	$	6,437	$	281	$	32,753

	For the Three Months Ended March 31, 2019
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	127,894	$	7,917	$	2,696	$	138,507
Cost of services revenues		95,995		3,770		1,915		101,680
Gross profit		31,899		4,147		781		36,827
General and administrative expenses		12,539		1,590		686		14,815
Segment operating income	$	19,360	$	2,557	$	95	$	22,012

	For the Three Months Ended March 31,
	2020			2019
	(Amounts in Thousands)
Segment reconciliation:
Total segment operating income	$	32,753		$	22,012

Items not allocated at segment level:
Other general and administrative expenses		19,205			14,442
Depreciation and amortization		2,887			2,074
Interest income		(334	)		(215	)
Interest expense		908			618
Income before income taxes	$	10,087		$	5,093

Long-Term Debt (Tables)

3 Months Ended

Mar. 31, 2020

Long Term Debt [Abstract]

Schedule of Long-Term Debt

Long-term debt consisted of the following:

	March 31, 2020			December 31, 2019
	(Amounts in Thousands)
Revolving loan under the credit facility	$	43,458		$	43,458
Term loan under the credit facility		18,865			18,865
Financing leases		12			21
Less unamortized issuance costs		(2,267	)		(2,452	)
Total	$	60,068		$	59,892
Less current maturities		(956	)		(728	)
Long-term debt	$	59,112		$	59,164

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Commitments and Contingencies

3 Months Ended

Mar. 31, 2020

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

10. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

Government Actions to Mitigate COVID-19’s Impact

On January 31, 2020, the Department of Health and Human Services (“HHS”) Secretary declared a national public health emergency due to a novel coronavirus. In March 2020, the World Health Organization declared the outbreak of COVID-19, a disease caused by this novel coronavirus, a pandemic. This disease continues to spread throughout the United States and other parts of the world. It is impossible to predict the effect and ultimate impact of the COVID-19 pandemic as the situation is rapidly evolving.

In recognition of the significant threat to the liquidity of financial markets posed by the COVID-19 pandemic, the Federal Reserve and Congress have taken dramatic actions to provide liquidity to businesses and the banking system in the United States. For example, on March 27, 2020, the President signed into law the Coronavirus Aid, Relief and Economic Security Act of 2020 (the “CARES Act”), a sweeping stimulus bill intended to bolster the U.S. economy. On April 24, 2020, the Paycheck Protection Program and Health Care Enhancement Act (“PPPHCE Act”) was enacted, an expansion of the CARES Act. Together, the CARES Act and the PPPHCE Act authorize $175 billion in funding to be distributed to health care providers through Relief Fund. This funding is intended to support healthcare providers by reimbursing them for healthcare-related expenses or lost revenues attributable to COVID-19. In addition to relief funding, the CARES Act includes temporary changes to Medicare and Medicaid payment rules, relief from certain accounting provisions and provisions relating to refundable payroll tax credits, deferral of the employer portion of certain payroll taxes, net operating loss carrybacks, and other areas. The payroll tax deferral requires that the deferred payroll taxes be paid over two years, with half of the amount required to be paid by December 31, 2021 and the other half by December 31, 2022.

Leases (Tables)

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Amounts Reported in Unaudited and Audited Condensed Consolidated Balance Sheets for Operating Leases

Amounts reported in the Company’s Unaudited Condensed Consolidated Balance Sheets as of March 31, 2020 and Audited Consolidated Balance Sheets as of December 31, 2019 for our operating leases were as follows:

	March 31, 2020		December 31, 2019
	(Amounts in Thousands)
Operating lease assets, net	$	20,703	$	21,111

Short-term operating lease liabilities (in accrued expenses)		7,425		7,234
Long-term operating lease liabilities		13,638		14,301
Total operating lease liabilities	$	21,063	$	21,535

Components of Lease Cost Reported in General and Administrative Expenses in Unaudited Condensed Consolidated Statements of Income

Components of lease cost were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

	For the Three Months Ended March 31, (Amounts in Thousands)
	2020		2019
Operating lease costs	$	2,118	$	1,646
Short-term lease costs		266		64
Total lease cost	$	2,384	$	1,710

Schedule of Weighted Average Remaining Lease Terms and Discount Rates

Weighted average remaining lease terms and discount rates were as follows:

	March 31, 2020			December 31, 2019
Operating leases:
Weighted average remaining lease term		3.29			3.42
Weighted average discount rate		5.05	%		5.14	%

Summary of Remaining Operating Lease Payments

A summary of our remaining operating lease payments as of March 31, 2020 were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended March 31,
2021	$	8,117
2022		6,818
2023		4,160
2024		2,323
2025		1,382
Thereafter		158
Total future minimum rental commitments		22,958
Less: Imputed interest		(1,895	)
Total lease liabilities	$	21,063

Supplemental Cash Flows Information

	For the Three Months Ended March 31, (Amounts in Thousands)
	2020		2019
Supplemental Cash Flows Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,171	$	1,639

Right-of-use assets obtained in exchange for lease obligations:
Operating leases		1,439		801

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net service revenues	$ 190,216	$ 138,507
Cost of service revenues	134,381	101,680
Gross profit	55,835	36,827
General and administrative expenses	42,287	29,257
Depreciation and amortization	2,887	2,074
Total operating expenses	45,174	31,331
Operating income	10,661	5,496
Interest income	(334)	(215)
Interest expense	908	618
Total interest expense, net	574	403
Income before income taxes	10,087	5,093
Income tax expense	1,429	797
Net income	$ 8,658	$ 4,296
Net income per common share
Basic income per share	$ 0.56	$ 0.33
Diluted income per share	$ 0.54	$ 0.32
Weighted average number of common shares and potential common shares outstanding:
Basic	15,519	12,995
Diluted	15,907	13,381

Significant Payors (Narrative) (Details)	3 Months Ended		12 Months Ended
Significant Payors (Narrative) (Details)	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Revenues [Member] \| Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	23.20%	29.10%
Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	37.70%	41.00%
Accounts Receivable [Member] \| Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	18.70%		25.10%

Subsequent Events

3 Months Ended

Mar. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

13. Subsequent Events

In April 2020, the Company received grants in an aggregate principal amount of $6.9 million, for which it did not apply, from the Public Health and Social Services Emergency Fund (“Relief Fund”) under Division A, Title I of the CARES Act as part of the automatic general distributions by HHS. The Company returned these funds in June 2020.

On July 1, 2020, we completed the acquisition of A Plus Health Care, Inc. (“A Plus”) for approximately $12.2 million, with funding provided by cash on hand. With the purchase of A Plus, we expanded our personal care services in the state of Montana. The Company is currently assessing the fair value of identifiable net assets acquired.

Significant Payors (Tables)

3 Months Ended

Mar. 31, 2020

Significant Payors [Abstract]

Schedule of Revenue by Payor Type

For the three months ended March 31, 2020 and 2019 the Company’s revenue by payor type was as follows:

	Personal Care
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
State, local and other governmental programs	$	79,346		49.4	%	$	71,642		56.0	%
Managed care organizations		72,110		44.9			47,726		37.3
Private pay		5,270		3.3			4,990		3.9
Commercial insurance		2,576		1.6			1,856		1.5
Other		1,363		0.8			1,680		1.3
Total personal care segment net service revenues	$	160,665		100.0	%	$	127,894		100.0	%

	Hospice
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	23,219		92.1	%	$	7,390		93.3	%
Managed care organizations		1,385		5.5			361		4.6
Other		608		2.4			166		2.1
Total hospice segment net service revenues	$	25,212		100.0	%	$	7,917		100.0	%

	Home Health
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	3,470		80.0	%	$	2,199		81.6	%
Managed care organizations		807		18.6			414		15.4
Other		62		1.4			83		3.0
Total home health segment net service revenues	$	4,339		100.0	%	$	2,696		100.0	%

Schedule of Revenue by Geographic Location

The percentages of segment revenue for each of these significant states for the three months ended March 31, 2020 and 2019 were as follows:

	Personal Care
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Illinois	$	71,545		44.5	%	$	56,849		44.4	%
New York		31,838		19.8			17,813		13.9
New Mexico		20,694		12.9			17,208		13.5
All other states		36,588		22.8			36,024		28.2
Total personal care segment net service revenues	$	160,665		100.0	%	$	127,894		100.0	%

	Hospice
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	11,009		43.7	%	$	7,917		100.0	%
All other states		14,203		56.3			—		—
Total hospice segment net service revenues	$	25,212		100.0	%	$	7,917		100.0	%

	Home Health
	For the Three Months Ended March 31,
	2020					2019
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	4,339		100.0	%	$	2,696		100.0	%
Total home health segment net service revenues	$	4,339		100.0	%	$	2,696		100.0	%

Revision of Previously Issued Financial Statements

3 Months Ended

Mar. 31, 2020

Accounting Changes And Error Corrections [Abstract]

Revision of Previously Issued Financial Statements

3. Revision of Previously Issued Financial Statements

In connection with management finalizing their financial reporting close process for the year ended December 31, 2019, management identified certain immaterial errors impacting the current period and previous periods dating back to periods prior to 2017, including interim periods within those years. Specifically, management determined there were certain errors in the information utilized to accurately estimate the implicit price concessions necessary to reduce net service revenues to the amount expected to be collected. Accordingly, management determined that our accounts receivable allowance was understated. The correction reflects the impact on the Company’s income tax provision and related accounts as a result of correcting for the error as discussed above. Additionally, the Company identified and corrected other immaterial unrelated income tax items impacting deferred tax assets and other immaterial items.

Management evaluated the impact of the errors on all previously issued financial statements and concluded such previously issued financial statements were not materially misstated; however, to reflect such corrections in the quarter ended December 31, 2019 financial statements would materially misstate the 2019 fiscal year. Accordingly, management revised previously issued financial statements to correct for the impact of the errors. The Company’s consolidated financial statements have been revised from the amounts previously reported to correct these immaterial errors as shown in the tables below and are reflected throughout the financial statements and related notes, as applicable.

The Consolidated Statements of Income has been revised to reflect the correction for the three months ended March 31, 2019 as follows (amounts in thousands, except per share data):

	For the Three Months Ended March 31, 2019
	As
	Previously					As
	Reported		Revision			Revised
Net service revenues	$	139,254	$	(747	)	$	138,507
Gross profit		37,574		(747	)		36,827
Operating income		6,243		(747	)		5,496
Income before income taxes		5,840		(747	)		5,093
Income tax expense		978		(181	)		797
Net income	$	4,862	$	(566	)	$	4,296
Basic income per share	$	0.37	$	(0.04	)	$	0.33
Diluted income per share	$	0.36	$	(0.04	)	$	0.32

The cumulative effect of the adjustments on all prior periods decreased retained earnings as of January 1, 2019 and March 31, 2019 as reflected below (amounts in thousands):

	Common Stock				Additional Paid in Capital		Retained Earnings			Total Stockholders' Equity
	Shares		Amount
Balance at January 1, 2019		13,126	$	13	$	177,683	$	97,837		$	275,533
Revision		—		—		—		(7,042	)		(7,042	)
Balance at January 1, 2019, as revised		13,126	$	13	$	177,683	$	90,795		$	268,491

Balance at March 31, 2019		13,178	$	13	$	178,916	$	102,699		$	281,628
Revision		—		—		—		(7,608	)		(7,608	)
Balance at March 31, 2019, as revised		13,178	$	13	$	178,916	$	95,091		$	274,020

Additionally, the Consolidated Statement of Cash Flows has been revised to reflect the correction for the three months ended March 31, 2019 as follows (amounts in thousands):

	For the Three Months Ended March 31, 2019
	As
	Previously						As
	Reported			Revision			Revised
Net income	$	4,862		$	(566	)	$	4,296
Deferred income taxes		121			(181	)		(60	)
Accounts receivable		(12,989	)		747			(12,242	)
Net cash provided by operating activities	$	(3,197	)	$	—		$	(3,197	)

Acquisitions

3 Months Ended

Mar. 31, 2020

Business Combinations [Abstract]

Acquisitions

5. Acquisitions

The Company’s acquisitions have been accounted for in accordance with ASC Topic 805, Business Combinations, and the resulting goodwill and other intangible assets were accounted for under ASC Topic 350, Goodwill and Other Intangible Assets. Under business combination accounting, the assets and liabilities are generally recognized at their fair values and the difference between the consideration transferred, excluding transaction costs, and the fair values of the assets and liabilities is recognized as goodwill. The results of each business acquisition are included on the Unaudited Condensed Consolidated Statements of Income from the date of the acquisition.

Management’s assessment of qualitative factors affecting goodwill for each acquisition includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations and the payor profile in the markets.

Hospice Partners

On October 1, 2019, the Company completed the acquisition of the assets of Hospice Partners of America, LLC (“Hospice Partners”). The purchase price was approximately $135.6 million. The purchase of Hospice Partners was funded through a portion of the net proceeds of our public offering of an aggregate 2,300,000 shares of common stock, par value $0.001 per share, including 300,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares at a public offering price of $79.50 per share, which the Company completed on September 9, 2019 (the “Public Offering”). With the purchase of Hospice Partners, we expanded our hospice operations through 21 locations in Idaho, Kansas, Missouri, Oregon, Texas and Virginia. The related acquisition costs were $0.1 million for the three months ended March 31, 2020 and integration costs were $0.8 million for the three months ended March 31, 2020. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	112,283
Identifiable intangible assets		18,090
Cash		5,705
Property and equipment		164
Accounts receivable		6,788
Operating lease assets, net		2,425
Other assets		632
Accounts payable		(1,631	)
Accrued expenses		(4,625	)
Accrued payroll		(1,108	)
Deferred tax liability		(1,540	)
Long-term operating lease liabilities		(1,615	)
Total purchase price	$	135,568

Identifiable intangible assets acquired consist of $9.5 million in trade names with estimated useful lives of fifteen years, $2.5 million in non-competition agreements with estimated useful lives of three to five years and $6.1 million of indefinite lived state licenses. The preliminary estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Hospice Partners acquisition accounted for $14.2 million of net service revenues and $3.1 million of operating income for the three months ended March 31, 2020.

Alliance Home Health Care

On August 1, 2019, the Company completed the acquisition of all of the assets of Alliance Home Health Care (“Alliance”). The purchase price was approximately $23.5 million. The purchase of Alliance was funded through the Company’s revolving credit facility and available cash. With the purchase of Alliance, the Company expanded its personal care, home health and hospice operations in the state of New Mexico. The related integration costs were $0.1 million for the three months ended March 31, 2020. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s final valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	16,859
Identifiable intangible assets		5,422
Cash		173
Accounts receivable		1,796
Accounts payable		(302	)
Other liabilities		(490	)
Total purchase price	$	23,458

Identifiable intangible assets acquired consist of $1.1 million in state licenses, subject to amortization, with an estimated useful life of ten years and $4.3 million of indefinite lived state licenses. The estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Alliance acquisition accounted for $4.7 million of net service revenues and $1.1 million of operating income for the three months ended March 31, 2020.

VIP Health Care Services

On June 1, 2019, the Company completed the acquisition of all of the assets of VIP Health Care Services (“VIP”). The purchase price was approximately $29.9 million. The purchase of VIP was funded through a combination of the Company’s delayed draw term loan portion of its credit facility and available cash. With the purchase of VIP, the Company expanded its personal care operations in the state of New York and into the New York City metropolitan area. The related integration costs were $0.1 million for the three months ended March 31, 2020. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	10,544
Identifiable intangible assets		15,370
Cash		110
Accounts receivable		6,064
Operating lease assets, net		2,278
Other assets		30
Property and equipment		27
Accounts payable		(462	)
Accrued expenses		(770	)
Accrued payroll		(1,742	)
Long-term operating lease liabilities		(1,531	)
Total purchase price	$	29,918

Identifiable intangible assets acquired consist of $10.7 million in state licenses, subject to amortization, and $4.7 million in customer relationships, with estimated useful lives of six and eight years, respectively. The estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The VIP acquisition accounted for $11.5 million of net service revenues and $0.1 million of operating loss for the three months ended March 31, 2020.

	For the Three Months Ended March 31, 2019 (Amounts in Thousands)
Net service revenues	$	171,487
Operating income		10,042
Net income		8,113
Net income per common share
Basic income per share	$	0.62

The pro forma disclosures in the table above include adjustments for amortization of intangible assets, tax expense and acquisition costs to reflect results that are more representative of the combined results of the transactions as if Hospice Partners, Alliance and VIP had been acquired effective January 1, 2019. This pro forma information is presented for illustrative purposes only and may not be indicative of the results of operations that would have actually occurred. In addition, future results may vary significantly from the results reflected in the pro forma information. The unaudited pro forma financial information does not reflect the impact of future events that may occur after the acquisition, such as anticipated cost savings from operating synergies.

Subsequent Events (Narrative) (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended
	Jul. 01, 2020	Apr. 30, 2020	Mar. 31, 2020
Subsequent Event [Line Items]
Total purchase price for business acquisition			$ 87
Subsequent Event [Member] \| A Plus Health Care, Inc [Member]
Subsequent Event [Line Items]
Total purchase price for business acquisition	$ 12,200
Subsequent Event [Member] \| Relief Fund [Member]
Subsequent Event [Line Items]
Aggregate principal amount of grants received under CARES Act		$ 6,900

Goodwill and Intangible Assets (Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Finite Lived Intangible Assets [Line Items]
Intangible assets with indefinite lives	$ 13,306
Intangible assets subject to amortization:
Gross carrying amount	95,739
Accumulated amortization	(53,741)
Intangible assets subject to amortization, net	41,998
Total intangible assets at March 31, 2020	55,304	$ 57,079
Customer And Referral Relationships [Member]
Intangible assets subject to amortization:
Gross carrying amount	48,028
Accumulated amortization	(36,197)
Intangible assets subject to amortization, net	11,831
Total intangible assets at March 31, 2020	11,831
Trade Names And Trademarks [Member]
Intangible assets subject to amortization:
Gross carrying amount	31,036
Accumulated amortization	(13,537)
Intangible assets subject to amortization, net	17,499
Total intangible assets at March 31, 2020	17,499
Non-competition Agreements [Member]
Intangible assets subject to amortization:
Gross carrying amount	4,655
Accumulated amortization	(2,402)
Intangible assets subject to amortization, net	2,253
Total intangible assets at March 31, 2020	2,253
State Licenses [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets with indefinite lives	13,306
Intangible assets subject to amortization:
Gross carrying amount	12,020
Accumulated amortization	(1,605)
Intangible assets subject to amortization, net	10,415
Total intangible assets at March 31, 2020	$ 23,721

Nature of Operations, Consolidation, and Presentation of Financial Statements (Narrative) (Details)	3 Months Ended
	Mar. 31, 2020 segment
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Number of operating segments	3

Significant Payors (Revenue by Geographic Location) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net service revenues	$ 190,216	$ 138,507
Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Concentration risk, percentage	37.70%	41.00%
Personal Care [Member]
Net service revenues	$ 160,665	$ 127,894
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues	$ 160,665	$ 127,894
Concentration risk, percentage	100.00%	100.00%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Net service revenues	$ 71,545	$ 56,849
Concentration risk, percentage	44.50%	44.40%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New York [Member]
Net service revenues	$ 31,838	$ 17,813
Concentration risk, percentage	19.80%	13.90%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues	$ 20,694	$ 17,208
Concentration risk, percentage	12.90%	13.50%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| All Other States [Member]
Net service revenues	$ 36,588	$ 36,024
Concentration risk, percentage	22.80%	28.20%
Hospice [Member]
Net service revenues	$ 25,212	$ 7,917
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues	$ 25,212	$ 7,917
Concentration risk, percentage	100.00%	100.00%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues	$ 11,009	$ 7,917
Concentration risk, percentage	43.70%	100.00%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| All Other States [Member]
Net service revenues	$ 14,203
Concentration risk, percentage	56.30%
Home Health [Member]
Net service revenues	$ 4,339	$ 2,696
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues	$ 4,339	$ 2,696
Concentration risk, percentage	100.00%	100.00%
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues	$ 4,339	$ 2,696
Concentration risk, percentage	100.00%	100.00%

Segment Information (Tables)

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Summary of Segment Information

	For the Three Months Ended March 31, 2020
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	160,665	$	25,212	$	4,339	$	190,216
Cost of services revenues		119,027		12,318		3,036		134,381
Gross profit		41,638		12,894		1,303		55,835
General and administrative expenses		15,603		6,457		1,022		23,082
Segment operating income	$	26,035	$	6,437	$	281	$	32,753

	For the Three Months Ended March 31, 2019
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	127,894	$	7,917	$	2,696	$	138,507
Cost of services revenues		95,995		3,770		1,915		101,680
Gross profit		31,899		4,147		781		36,827
General and administrative expenses		12,539		1,590		686		14,815
Segment operating income	$	19,360	$	2,557	$	95	$	22,012

	For the Three Months Ended March 31,
	2020			2019
	(Amounts in Thousands)
Segment reconciliation:
Total segment operating income	$	32,753		$	22,012

Items not allocated at segment level:
Other general and administrative expenses		19,205			14,442
Depreciation and amortization		2,887			2,074
Interest income		(334	)		(215	)
Interest expense		908			618
Income before income taxes	$	10,087		$	5,093

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ 8,658	$ 4,296
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:
Depreciation and amortization	2,887	2,074
Deferred income taxes	42	(60)
Stock-based compensation	1,407	1,233
Amortization of debt issuance costs under the credit facility	186	161
Provision for doubtful accounts	224	57
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	8,777	(12,242)
Prepaid expenses and other current assets	973	2,494
Accounts payable	(1,976)	(689)
Accrued expenses and other long-term liabilities	(736)	(521)
Net cash provided by (used in) operating activities	20,442	(3,197)
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(87)
Purchases of property and equipment	(2,747)	(1,006)
Net cash used in investing activities	(2,834)	(1,006)
Cash flows from financing activities:
Payments on financing lease obligations	(10)	(33)
Cash received from exercise of stock options	1,151
Net cash provided by (used in) financing activities	1,141	(33)
Net change in cash	18,749	(4,236)
Cash, at beginning of period	111,714	70,406
Cash, at end of period	130,463	66,170
Supplemental disclosures of cash flow information:
Cash paid for interest	731	723
Cash paid for income taxes	$ 1,954	$ 1,082

Acquisitions (Narrative) (Details) $ / shares in Units, $ in Thousands				3 Months Ended
	Oct. 01, 2019 USD ($) location $ / shares shares	Aug. 01, 2019 USD ($)	Jun. 01, 2019 USD ($)	Mar. 31, 2020 USD ($) $ / shares	Mar. 31, 2019 USD ($)	Dec. 31, 2019 $ / shares
Business Acquisition [Line Items]
Total purchase price for business acquisition				$ 87
Common stock, par value \| $ / shares				$ 0.001		$ 0.001
Net service revenues				$ 190,216	$ 138,507
Operating income (loss) from continuing operations				$ 10,087	$ 5,093
Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives				3 years
Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives				25 years
Hospice Partners [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition	$ 135,600
Number of locations \| location	21
Acquisition related costs				$ 100
Integration costs				800
Net service revenues				14,200
Operating income (loss) from continuing operations				3,100
Hospice Partners [Member] \| Trade Names [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives	15 years
Identifiable intangible assets acquired	$ 9,500
Hospice Partners [Member] \| Non-competition Agreements [Member]
Business Acquisition [Line Items]
Identifiable intangible assets acquired	$ 2,500
Hospice Partners [Member] \| Non-competition Agreements [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives	3 years
Hospice Partners [Member] \| Non-competition Agreements [Member] \| Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives	5 years
Hospice Partners [Member] \| State Licenses [Member]
Business Acquisition [Line Items]
Indefinite lived intangible assets acquired	$ 6,100
Hospice Partners [Member] \| Common Stock [Member]
Business Acquisition [Line Items]
Shares issued during period \| shares	2,300,000
Common stock, par value \| $ / shares	$ 0.001
Public offering price, per share \| $ / shares	$ 79.50
Hospice Partners [Member] \| Common Stock [Member] \| Over Allotment Option [Member]
Business Acquisition [Line Items]
Shares issued during period \| shares	300,000
Alliance Home Health Care [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition		$ 23,500
Integration costs				100
Alliance Home Health Care [Member] \| New York [Member]
Business Acquisition [Line Items]
Net service revenues				4,700
Operating income (loss) from continuing operations				1,100
Alliance Home Health Care [Member] \| State Licenses [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives		10 years
Identifiable intangible assets acquired		$ 1,100
Indefinite lived intangible assets acquired		$ 4,300
VIP Health Care Services [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition			$ 29,900
Integration costs				100
VIP Health Care Services [Member] \| New York [Member]
Business Acquisition [Line Items]
Net service revenues				11,500
Operating income (loss) from continuing operations				$ 100
VIP Health Care Services [Member] \| State Licenses [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives			6 years
Identifiable intangible assets acquired			$ 10,700
VIP Health Care Services [Member] \| Customer Relationships [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives			8 years
Identifiable intangible assets acquired			$ 4,700

Revision of Previously Issued Financial Statements (Cumulative Effect of Adjustments on all Periods Decreased Retained Earnings) (Details) - USD ($) shares in Thousands, $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance	$ 486,808	$ 475,592	$ 274,020	$ 268,491
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance			281,628	275,533
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance			(7,608)	(7,042)
Common Stock [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance	$ 16	$ 15	$ 13	$ 13
Balance, shares	15,660	15,617	13,178	13,126
Common Stock [Member] \| As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance			$ 13	$ 13
Balance, shares			13,178	13,126
Additional Paid-in Capital [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance	$ 362,102	$ 359,545	$ 178,916	$ 177,683
Additional Paid-in Capital [Member] \| As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance			178,916	177,683
Retained Earnings [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance	$ 124,690	$ 116,032	95,091	90,795
Retained Earnings [Member] \| As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance			102,699	97,837
Retained Earnings [Member] \| Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Balance			$ (7,608)	$ (7,042)

Acquisitions (Unaudited Pro Forma Condensed Consolidated Income Statement Information) (Details) - Hospic Partners, Alliance and VIP [Member] $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($) $ / shares
Business Acquisition [Line Items]
Net service revenues	$ 171,487
Operating income	10,042
Net income	$ 8,113
Basic income per share \| $ / shares	$ 0.62

Leases (Components of Lease Cost Reported in General and Administrative Expenses in Unaudited Condensed Consolidated Statements of Income) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease costs	$ 2,118	$ 1,646
Short-term lease costs	266	64
Total lease cost	$ 2,384	$ 1,710

Income Taxes (Narrative) (Details)	3 Months Ended
Income Taxes (Narrative) (Details)	Mar. 31, 2020	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Effective income tax rate	14.20%	15.60%
Excess tax benefit	12.20%	8.70%

Leases

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Leases

4. Leases

We have historically entered into operating leases for local branches, our corporate headquarters and certain equipment. The Company’s current leases have expiration dates through 2026. Certain of our arrangements have free rent periods and/or escalating rent payment provisions. We recognize rent expense on a straight-line basis over the lease term. Certain of the Company’s leases include termination options and renewal options for periods ranging from one to five years. Because we are not reasonably certain to exercise these renewal options, the options generally are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments.

When available, we use the rate implicit in the lease to discount lease payments to present value; however, most of our leases do not provide a readily determinable implicit rate. Therefore, we must estimate our incremental borrowing rate to discount the lease payments based on information available at lease commencement.

	March 31, 2020		December 31, 2019
	(Amounts in Thousands)
Operating lease assets, net	$	20,703	$	21,111

Short-term operating lease liabilities (in accrued expenses)		7,425		7,234
Long-term operating lease liabilities		13,638		14,301
Total operating lease liabilities	$	21,063	$	21,535

Lease Costs

Components of lease cost were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

	For the Three Months Ended March 31, (Amounts in Thousands)
	2020		2019
Operating lease costs	$	2,118	$	1,646
Short-term lease costs		266		64
Total lease cost	$	2,384	$	1,710

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:

	March 31, 2020			December 31, 2019
Operating leases:
Weighted average remaining lease term		3.29			3.42
Weighted average discount rate		5.05	%		5.14	%

Maturity of Lease Liabilities

A summary of our remaining operating lease payments as of March 31, 2020 were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended March 31,
2021	$	8,117
2022		6,818
2023		4,160
2024		2,323
2025		1,382
Thereafter		158
Total future minimum rental commitments		22,958
Less: Imputed interest		(1,895	)
Total lease liabilities	$	21,063

Supplemental cash flows information

	For the Three Months Ended March 31, (Amounts in Thousands)
	2020		2019
Supplemental Cash Flows Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,171	$	1,639

Right-of-use assets obtained in exchange for lease obligations:
Operating leases		1,439		801

Financing Leases

Some of our financing leases include provisions to purchase the asset at the conclusion of the lease. Financing leases were not material as of March 31, 2020 and December 31, 2019.

Leases (Schedule of Weighted Average Remaining Lease Terms and Discount Rates) (Details)	Mar. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Weighted average remaining lease term	3 years 3 months 14 days	3 years 5 months 1 day
Weighted average discount rate	5.05%	5.14%

Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Summary Of Significant Accounting Policies [Line Items]
Provision for doubtful accounts	$ 0.2
Allowance for doubtful accounts	$ 0.8		$ 1.0
Stock Options [Member]
Summary Of Significant Accounting Policies [Line Items]
Number of potential diluted securities outstanding	585,000	685,000
Number of stock options included in calculation	311,000	303,000
Restricted Stock [Member]
Summary Of Significant Accounting Policies [Line Items]
Number of potential diluted securities outstanding	77,000	83,000
Shares of restricted stock awards included in calculation	84,000	153,000

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2020

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

6. Goodwill and Intangible Assets

A summary of the goodwill activity for the three months ended March 31, 2020 is provided below:

	Goodwill
	Personal Care			Hospice		Home Health		Total
	(Amounts in Thousands)
Goodwill as of December 31, 2019	$	126,577		$	146,983	$	1,808	$	275,368
Adjustments to previously recorded goodwill		(71	)		31		36		(4	)
Goodwill as of March 31, 2020	$	126,506		$	147,014	$	1,844	$	275,364

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names, trademarks and non-competition agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from three to twenty-five years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years. Goodwill and certain state licenses are not amortized pursuant to ASC Topic 350.

For the three months ended March 31, 2020, adjustments to the previously recorded goodwill are primarily adjustments to accounts receivable based on the final valuations.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following as of March 31, 2020:

	Customer and referral relationships			Trade names and trademarks			Non- competition agreements			State Licenses			Total
	(Amounts in Thousands)
Intangible assets with indefinite lives		—			—			—			13,306			13,306
Intangible assets subject to amortization:
Gross carrying amount		48,028			31,036			4,655			12,020			95,739
Accumulated amortization		(36,197	)		(13,537	)		(2,402	)		(1,605	)		(53,741	)
Intangible assets subject to amortization, net		11,831			17,499			2,253			10,415			41,998
Total intangible assets at March 31, 2020	$	11,831		$	17,499		$	2,253		$	23,721		$	55,304

Amortization expense related to the identifiable intangible assets amounted to $1.8 million and $1.3 million for the three months ended March 31, 2020 and 2019, respectively. The weighted average remaining lives of identifiable intangible assets as of March 31, 2020 is 8.8 years.

Goodwill and Intangible Assets (Summary of Goodwill and Related Adjustments) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020 USD ($)
Goodwill [Line Items]
Goodwill, at Beginning of Period	$ 275,368
Adjustments to previously recorded goodwill	(4)
Goodwill, at End of Period	275,364
Personal Care [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	126,577
Adjustments to previously recorded goodwill	(71)
Goodwill, at End of Period	126,506
Hospice [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	146,983
Adjustments to previously recorded goodwill	31
Goodwill, at End of Period	147,014
Home Health [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	1,808
Adjustments to previously recorded goodwill	36
Goodwill, at End of Period	$ 1,844